Porphyria cutanea tarda cost-effectiveness of therapy

Jump to navigation Jump to search

Porphyria cutanea tarda Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Porphyria cutanea tarda from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Porphyria cutanea tarda cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Porphyria cutanea tarda cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Porphyria cutanea tarda cost-effectiveness of therapy

CDC on Porphyria cutanea tarda cost-effectiveness of therapy

Porphyria cutanea tarda cost-effectiveness of therapy in the news

Blogs on Porphyria cutanea tarda cost-effectiveness of therapy

Directions to Hospitals Treating Cushing’s disease

Risk calculators and risk factors for Porphyria cutanea tarda cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Cost-Effectiveness of Therapy

References

Template:WS Template:WH